Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Adults With Chronic Genotype 3 HCV Infection

Gilead Sciences · 2014
ClinicalTrials.gov · Datasets · License: Public Domain · 2014
Open Source ↗
cirrhosishepatitis-c
hepatitis c virus infection, sofosbuvir, velpatasvir, sof/vel, gs-5816, hepatitis c, hcv, cirrhosis, genotype 3, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 909636
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.